DE01201546T1 - Osteogene Einrichtungen - Google Patents
Osteogene Einrichtungen Download PDFInfo
- Publication number
- DE01201546T1 DE01201546T1 DE0001225225T DE01201546T DE01201546T1 DE 01201546 T1 DE01201546 T1 DE 01201546T1 DE 0001225225 T DE0001225225 T DE 0001225225T DE 01201546 T DE01201546 T DE 01201546T DE 01201546 T1 DE01201546 T1 DE 01201546T1
- Authority
- DE
- Germany
- Prior art keywords
- protein
- osteogenic
- matrix
- mammal
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/24—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/34—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3608—Bone, e.g. demineralised bone matrix [DBM], bone powder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
- A61L27/3645—Connective tissue
- A61L27/365—Bones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
- A61L27/3645—Connective tissue
- A61L27/3654—Cartilage, e.g. meniscus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C8/00—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools
- A61C8/0003—Not used, see subgroups
- A61C8/0004—Consolidating natural teeth
- A61C8/0006—Periodontal tissue or bone regeneration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00365—Proteins; Polypeptides; Degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
Abstract
Verwendung einer Zusammensetzung, welche im wesentlichen aus einer einzigen Spezies eines osteogenen Proteins als osteogen aktivem Bestandteil besteht, wobei das Protein eine unpaarige Polypeptidkette aufweist, welche zum Induzieren von enchondraler Knochenbildung geeignet ist, wenn sie an einer Matrix angeordnet und einem Säuger implantiert wird, zur Herstellung eines Medikamentes zum Induzieren von enchondraler Knochenbildung.
Claims (15)
- Verwendung einer Zusammensetzung, welche im wesentlichen aus einer einzigen Spezies eines osteogenen Proteins als osteogen aktivem Bestandteil besteht, wobei das Protein eine unpaarige Polypeptidkette aufweist, welche zum Induzieren von enchondraler Knochenbildung geeignet ist, wenn sie an einer Matrix angeordnet und einem Säuger implantiert wird, zur Herstellung eines Medikamentes zum Induzieren von enchondraler Knochenbildung.
- Verwendung einer Zusammensetzung, welche im wesentlichen aus einer einzigen Spezies eines osteogenen Proteins als osteogen aktivem Bestandteil besteht, wobei das osteogene Protein nicht ein Paar von Polypeptidketten aufweist und zum Induzieren von enchondraler Knochenbildung geeignet ist, wenn sie an einer Matrix angeordnet und einem Säuger implantiert wird, zur Herstellung eines Medikamentes zum Induzieren von enchondraler Knochenbildung.
- Osteogenes Protein, welches eine unpaarige Polypeptidkette aufweist, die zum Induzieren von enchondraler Knochenbildung geeignet ist, wenn sie an einer Matrix angeordnet und einem Säuger implantiert wird, wobei das Protein in nicht glykolysierter Form vorliegt.
- Osteogenes Protein, welches eine Polypeptidkette aufweist, die zum Induzieren von enchondraler Knochenbildung geeignet ist, wenn sie an einer Matrix angeordnet und einem Säuger implantiert wird, wobei das Protein nicht ein Paar von Polypeptidketten aufweist und in nicht glykolysierter Form vorliegt.
- Verfahren zur Herstellung einer Polypeptidkette zur Verwendung bei der Herstellung eines aktiven osteogenen Proteins, wobei das Verfahren die folgenden Schritte umfaßt: (a) Bereitstellen von genetischem Material, welches das osteogene Protein codiert; (b) Einführen des genetischen Materials in eine prokaryotische Gastzelle; (c) Expression des genetischen Materials in der Gastzelle; und (d) Falten des exprimierten Proteins durch Oxidation.
- Verfahren nach Anspruch 5, wobei das Protein eine TGF-beta-artige Domäne mit Sieben-Cysteinen aufweist.
- Polypeptidkette, welche mittels eines Verfahrens nach Anspruch 5 oder 6 herstellbar ist.
- Verwendung nach Anspruch 1 oder 2, Protein nach Anspruch 3 oder 4, Verfahren nach Anspruch 5 oder 6 oder Polypeptid nach Anspruch 7, wobei das Protein (a) die Aminosäuresequenz VPKPCCAPT aufweist; oder (b) die Aminosäuresequenz aufweist; oder (c) die Aminosäuresequenz aufweist; oder (d) die Aminosäuresequenz aufweist; oder (e) die Aminosäuresequenz aufweist; oder (f) die Aminosäuresequenz aufweist; oder (g) diejenige Sequenz von Aminosäuren aufweist, welche durch eine DNS-Sequenz codiert wird, die durch Hybridisierung mit der Probe gemäß
13 erhältlich ist. - Verwendung nach Anspruch 1 oder 2, Protein nach Anspruch 3 oder 4, verfahren nach Anspruch 5 oder 6, Polypeptid nach Anspruch 7 oder Verwendung, Protein, Verfahren oder Polypeptid nach Anspruch 8, wobei das Protein: (a) in der glykolysierten, nativen Form ein scheinbares Molekulargewicht von etwa 30 kD aufweist, wie es mittels SDS-PAGE ermittelt worden ist; oder (b) in der deglykolysierten Form ein scheinbares Molekulargewicht von etwa 27 kD aufweist, wie es mittels SDS-PAGE ermittelt worden ist; oder (c) zwei Polypeptidketten aufweist, welche in der glykolysierten Form ein scheinbares Molekulargewicht von etwa 16 kD und 18 kD aufweisen; oder (d) zwei Polypeptidketten aufweist, welche in der nicht glykolysierten Form ein scheinbares Molekulargewicht von etwa 14 kD bis 16 kD aufweisen.
- Verfahren nach einem der Ansprüche 5 bis 9, wobei die Gastzelle eine Gastzelle von E. coli ist.
- Verfahren zur Herstellung einer osteogenen Einrichtung, welches die Anordnung eines Proteins nach einem der vorangehenden Ansprüche an einer Matrix umfaßt.
- Verfahren nach Anspruch 11, wobei die Einrichtung zur Implantation in einem Säuger geeignet ist und (a) eine biokompatible, in vivo biologisch abbaubare Matrix aufweist, welche Poren mit hinreichenden Abmessungen bildet, um die Einfuhr, Proliferation und Differenzierung von Wander-Progenitorzellen des Körpers dieses Säugers zu ermöglichen; und (b) das Protein an dieser Matrix angeordnet und diesen Zellen zugänglich ist.
- Verfahren nach Anspruch 13, wobei die Matrix ein dicht gepacktes partikuläres Material mit einer Partikelgröße im Bereich von 70 um bis 420 um aufweist.
- Verfahren nach einem der Ansprüche 11 bis 13, wobei die Matrix umfaßt: (a) allogenes Knochenmaterial, z.B. demineralisiertes, Protein extrahiertes, partikuläres, allogenes Knochenmaterial; (b) demineralisiertes, Protein extrahiertes, partikuläres, deglykolysiertes, xenogenes Knochenmaterial (welches z.B. mit einer Protease behandelt worden ist); (c) demineralisiertes, Protein extrahiertes, partikuläres, xenogenes, mit HF behandeltes Knochenmaterial; (d) Materialien aus der Gruppe Kollagen, Hydroxyapatit, Calciumphosphate (z.B. Tricalciumphosphat) und Polymere mit Monomeren aus Glykolsäure und/oder Milchsäure; (e) ein formstabiles, festes oder lose gebundenes, partikuläres Material, z.B. Kollagen; (f) ein poröses Feststoffmaterial; (g) zerkleinertes Gewebe, z.B. Muskelgewebe; oder (h) die Markhöhle von allogenem Knochenmaterial.
- Verfahren nach einem der Ansprüche 11 bis 14, wobei die Einrichtung zur Verwendung in der Therapie geeignet ist, z.B. zum Induzieren von lokaler Knorpel- und/oder enchondraler Knochenbildung in einem Säuger mittels Implantieren der Einrichtung in einen Säuger an einer Stelle, welche für Wander-Progenitorzellen zugänglich ist, für Periodontalbehandlungen, Knorpelbehandlungen, zur Beschleunigung von Allotransplantationsbehandlungen und zur Behandlung von Osteaarthritis oder zur Korrektur von vollständigen Frakturen, erworbenen oder angeborenen Schädelanomalien, anderen skelettalen oder dentalen Anomalien.
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/179,406 US4968590A (en) | 1988-04-08 | 1988-04-08 | Osteogenic proteins and polypeptides |
US179406 | 1988-04-08 | ||
US23263088A | 1988-08-15 | 1988-08-15 | |
US232630 | 1988-08-15 | ||
US315342 | 1989-02-23 | ||
US07/315,342 US5011691A (en) | 1988-08-15 | 1989-02-23 | Osteogenic devices |
Publications (1)
Publication Number | Publication Date |
---|---|
DE01201546T1 true DE01201546T1 (de) | 2004-07-08 |
Family
ID=27391116
Family Applications (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE68929453T Expired - Lifetime DE68929453T2 (de) | 1988-04-08 | 1989-04-07 | Osteogene Vorrichtungen |
DE0001221484T Pending DE01201555T1 (de) | 1988-04-08 | 1989-04-07 | Biosynthetische osteogene Proteine und solche enthaltende osteogene Einrichtungen |
DE68929472T Revoked DE68929472T2 (de) | 1988-04-08 | 1989-04-07 | Biosynthetische knochenbildende Proteine, und sie enthaltende knochenbildende Vorrichtungen |
DE68925773T Expired - Lifetime DE68925773T2 (de) | 1988-04-08 | 1989-04-07 | Osteogene vorrichtungen |
DE0001225225T Pending DE01201546T1 (de) | 1988-04-08 | 1989-04-07 | Osteogene Einrichtungen |
DE68927153T Expired - Lifetime DE68927153T2 (de) | 1988-04-08 | 1989-04-07 | Biosynthetische osteogene proteine und sie enthaltende osteogene vorrichtungen |
Family Applications Before (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE68929453T Expired - Lifetime DE68929453T2 (de) | 1988-04-08 | 1989-04-07 | Osteogene Vorrichtungen |
DE0001221484T Pending DE01201555T1 (de) | 1988-04-08 | 1989-04-07 | Biosynthetische osteogene Proteine und solche enthaltende osteogene Einrichtungen |
DE68929472T Revoked DE68929472T2 (de) | 1988-04-08 | 1989-04-07 | Biosynthetische knochenbildende Proteine, und sie enthaltende knochenbildende Vorrichtungen |
DE68925773T Expired - Lifetime DE68925773T2 (de) | 1988-04-08 | 1989-04-07 | Osteogene vorrichtungen |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE68927153T Expired - Lifetime DE68927153T2 (de) | 1988-04-08 | 1989-04-07 | Biosynthetische osteogene proteine und sie enthaltende osteogene vorrichtungen |
Country Status (8)
Country | Link |
---|---|
US (4) | US5814604A (de) |
EP (6) | EP0714665B1 (de) |
JP (5) | JP2522568B2 (de) |
AT (4) | ATE134647T1 (de) |
AU (2) | AU628050B2 (de) |
CA (2) | CA1341610C (de) |
DE (6) | DE68929453T2 (de) |
WO (2) | WO1989009788A2 (de) |
Families Citing this family (122)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5902741A (en) * | 1986-04-18 | 1999-05-11 | Advanced Tissue Sciences, Inc. | Three-dimensional cartilage cultures |
US6432919B1 (en) | 1986-07-01 | 2002-08-13 | Genetics Institute, Inc. | Bone morphogenetic protein-3 and compositions |
US5459047A (en) | 1986-07-01 | 1995-10-17 | Genetics Institute, Inc. | BMP-6 proteins |
US5366875A (en) * | 1986-07-01 | 1994-11-22 | Genetics Institute, Inc. | Methods for producing BMP-7 proteins |
US5106748A (en) * | 1986-07-01 | 1992-04-21 | Genetics Institute, Inc. | Dna sequences encoding 5 proteins |
US6150328A (en) * | 1986-07-01 | 2000-11-21 | Genetics Institute, Inc. | BMP products |
US5543394A (en) * | 1986-07-01 | 1996-08-06 | Genetics Institute, Inc. | Bone morphogenetic protein 5(BMP-5) compositions |
US5013649A (en) * | 1986-07-01 | 1991-05-07 | Genetics Institute, Inc. | DNA sequences encoding osteoinductive products |
US5187076A (en) * | 1986-07-01 | 1993-02-16 | Genetics Institute, Inc. | DNA sequences encoding BMP-6 proteins |
US5939388A (en) * | 1986-07-01 | 1999-08-17 | Rosen; Vicki A. | Methods of administering BMP-5 compositions |
US20070166353A1 (en) * | 1988-04-08 | 2007-07-19 | Stryker Corporation | Osteogenic proteins |
US6919308B2 (en) * | 1988-04-08 | 2005-07-19 | Stryker Corporation | Osteogenic devices |
DE68929453T2 (de) * | 1988-04-08 | 2003-11-20 | Stryker Corp | Osteogene Vorrichtungen |
US5266683A (en) * | 1988-04-08 | 1993-11-30 | Stryker Corporation | Osteogenic proteins |
US6586388B2 (en) * | 1988-04-08 | 2003-07-01 | Stryker Corporation | Method of using recombinant osteogenic protein to repair bone or cartilage defects |
EP0408649A4 (en) * | 1988-04-08 | 1991-11-27 | Genetics Institute, Inc. | Bone and cartilage inductive compositions |
US5108436A (en) * | 1988-09-29 | 1992-04-28 | Collagen Corporation | Implant fixation |
US5284756A (en) * | 1988-10-11 | 1994-02-08 | Lynn Grinna | Heterodimeric osteogenic factor |
US5106626A (en) * | 1988-10-11 | 1992-04-21 | International Genetic Engineering, Inc. | Osteogenic factors |
ATE162223T1 (de) * | 1989-03-28 | 1998-01-15 | Genetics Inst | Osteoinduktive zusammensetzungen |
CA2024629C (en) * | 1989-09-06 | 2001-07-24 | Taiheiyo Cement Corporation | Xenopus laevis bone morphogenic protein, dna encoding same and use thereof |
DK0448704T3 (da) * | 1989-10-17 | 1999-04-06 | Stryker Corp | Osteogene anordninger |
US7378392B1 (en) | 1990-05-16 | 2008-05-27 | Genetics Institute, Llc | Bone and cartilage inductive proteins |
US5688678A (en) * | 1990-05-16 | 1997-11-18 | Genetics Institute, Inc. | DNA encoding and methods for producing BMP-8 proteins |
US5645591A (en) | 1990-05-29 | 1997-07-08 | Stryker Corporation | Synthetic bone matrix |
WO1992007004A1 (en) * | 1990-10-18 | 1992-04-30 | Creative Biomolecules, Inc. | Osteogenic protein |
DK0643767T3 (da) * | 1990-10-18 | 1999-04-26 | Stryker Corp | Osteogene peptider |
EP0513334A4 (en) * | 1990-11-30 | 1993-08-04 | Celtrix Laboratories, Inc. | Use of a bone morphogenetic protein in synergistic combination with tgf--g(b) for bone repair |
US5206023A (en) * | 1991-01-31 | 1993-04-27 | Robert F. Shaw | Method and compositions for the treatment and repair of defects or lesions in cartilage |
US5656593A (en) * | 1991-03-11 | 1997-08-12 | Creative Biomolecules, Inc. | Morphogen induced periodontal tissue regeneration |
US5652118A (en) * | 1991-03-11 | 1997-07-29 | Creative Biomolecules, Inc. | Nucleic acid encoding a novel morphogenic protein, OP-3 |
US6090776A (en) * | 1991-03-11 | 2000-07-18 | Creative Bio Molecules, Inc. | Morphogen treatment of organ implants |
US5674844A (en) * | 1991-03-11 | 1997-10-07 | Creative Biomolecules, Inc. | Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases |
US6395883B1 (en) * | 1991-03-11 | 2002-05-28 | Curis, Inc. | Soluble morphogenic protein complex compositions of matter |
US6495513B1 (en) | 1991-03-11 | 2002-12-17 | Curis, Inc. | Morphogen-enhanced survival and repair of neural cells |
US6399569B1 (en) | 1991-03-11 | 2002-06-04 | Curis, Inc. | Morphogen treatments for limiting proliferation of epithelial cells |
US6800603B2 (en) | 1991-03-11 | 2004-10-05 | Curis, Inc. | Morphogen-induced neural cell adhesion |
US5849686A (en) * | 1991-03-11 | 1998-12-15 | Creative Biomolecules, Inc. | Morphogen-induced liver regeneration |
US6194376B1 (en) | 1991-03-11 | 2001-02-27 | Creative Biomolecules, Inc. | Method for modulating inflammatory response comprising administering morphogen |
US5707810A (en) * | 1991-03-11 | 1998-01-13 | Creative Biomolecules, Inc. | Method of diagnosing renal tissue damage or disease |
US6077823A (en) * | 1991-03-11 | 2000-06-20 | Creative Biomolecules, Inc. | Method for reducing tissue damage associated with ischemia-reperfusion or hypoxia injury |
US6211146B1 (en) * | 1991-03-11 | 2001-04-03 | Curis, Inc. | 60A protein-induced morphogenesis |
CA2363965C (en) * | 1991-03-11 | 2010-05-18 | Curis, Inc. | Protein-induced morphogenesis |
ATE203166T1 (de) * | 1991-03-11 | 2001-08-15 | Curis Inc | Protein-induzierende morphogenese |
US5972884A (en) * | 1991-03-11 | 1999-10-26 | Creative Biomolecules, Inc. | Morphogen treatment of gastrointestinal ulcers |
US5652337A (en) * | 1991-03-11 | 1997-07-29 | Creative Biomolecules, Inc. | OP-3-induced morphogenesis |
US5650276A (en) * | 1991-03-11 | 1997-07-22 | Creative Biomolecules, Inc. | Morphogenic protein screening method |
US7056882B2 (en) | 1991-03-11 | 2006-06-06 | Curis, Inc. | Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases |
US5118667A (en) * | 1991-05-03 | 1992-06-02 | Celtrix Pharmaceuticals, Inc. | Bone growth factors and inhibitors of bone resorption for promoting bone formation |
CA2102808A1 (en) | 1991-05-10 | 1992-11-11 | Hanne Bentz | Targeted delivery of bone growth factors |
US5693615A (en) * | 1991-06-05 | 1997-12-02 | The Procter & Gamble Company | Therapeutic compositions for osteoinduction |
ATE142460T1 (de) * | 1991-06-21 | 1996-09-15 | Genetics Inst | Osteogene proteine enthaltende arzneimittel |
US6287816B1 (en) | 1991-06-25 | 2001-09-11 | Genetics Institute, Inc. | BMP-9 compositions |
EP0601135B1 (de) * | 1991-08-30 | 2005-11-02 | Curis, Inc. | Osteogenische proteine in der behandlung von metabolischen knochenkrankheiten |
EP0601106B2 (de) * | 1991-08-30 | 2003-11-05 | Curis, Inc. | Morphogen-induzierte Modulation von entzündlichen Antworten |
US6022853A (en) * | 1991-08-30 | 2000-02-08 | Creative Biomolecules, Inc. | Morphogen-enriched dietary composition |
US5270300A (en) * | 1991-09-06 | 1993-12-14 | Robert Francis Shaw | Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone |
WO1993009229A1 (en) | 1991-11-04 | 1993-05-13 | Genetics Institute, Inc. | Recombinant bone morphogenetic protein heterodimers, compositions and methods of use |
US20080233170A1 (en) * | 1992-02-21 | 2008-09-25 | Stryker Corporation | Osteogenic Proteins |
CA2141554C (en) * | 1992-07-31 | 2003-02-11 | David C. Rueger | Morphogen-induced nerve regeneration and repair |
WO1994010203A2 (en) * | 1992-11-03 | 1994-05-11 | Creative Biomolecules, Inc. | Op-3-induced morphogenesis |
DE69434914T2 (de) * | 1993-03-04 | 2007-10-31 | Stryker Corp., Kalamazoo | Verfahren und zusammensetzungen zur herstellung von rekombinantem osteogenischem protein |
US5906827A (en) * | 1994-06-03 | 1999-05-25 | Creative Biomolecules, Inc. | Matrix for the manufacture of autogenous replacement body parts |
US6040431A (en) * | 1995-06-07 | 2000-03-21 | Stryker Corporation | Single chain analogs of the TGF-β superfamily (morphons) |
US5674292A (en) | 1995-06-07 | 1997-10-07 | Stryker Corporation | Terminally sterilized osteogenic devices and preparation thereof |
ATE364629T1 (de) * | 1996-01-22 | 2007-07-15 | Curis Inc | Methoden zur herstellung von op-1 morphogen analoge |
US6492508B1 (en) | 1996-06-03 | 2002-12-10 | United States Surgical Corp. A Division Of Tyco Healthcare Group | Nucleic acids encoding extracellular matrix proteins |
ZA9711580B (en) * | 1996-12-25 | 1999-09-23 | Hoechst Marion Roussel Ltd | Process for the production of purified dimeric bone morphogenetic factors. |
US6034062A (en) * | 1997-03-13 | 2000-03-07 | Genetics Institute, Inc. | Bone morphogenetic protein (BMP)-9 compositions and their uses |
US20010016646A1 (en) | 1998-03-20 | 2001-08-23 | David C. Rueger | Osteogenic devices and methods of use thereof for repair of endochondral bone, osteochondral and chondral defects |
US7041641B2 (en) | 1997-03-20 | 2006-05-09 | Stryker Corporation | Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects |
EP2309261A1 (de) * | 1997-05-30 | 2011-04-13 | Stryker Corporation | Verfahren zur Beurteilung von Gewebemorphogenese und- aktivität |
US5972368A (en) | 1997-06-11 | 1999-10-26 | Sdgi Holdings, Inc. | Bone graft composites and spacers |
US7147839B2 (en) | 1998-05-29 | 2006-12-12 | Curis, Inc. | Methods for evaluating tissue morphogenesis and activity |
US6846906B1 (en) | 1998-10-07 | 2005-01-25 | Stryker Corporation | Modified proteins of the TGF-β superfamily, including morphogenic proteins |
JP3786533B2 (ja) | 1998-11-12 | 2006-06-14 | 善彦 西村 | ペプチド及び骨形成促進剤 |
US6231528B1 (en) | 1999-01-15 | 2001-05-15 | Jonathan J. Kaufman | Ultrasonic and growth factor bone-therapy: apparatus and method |
DE19906096A1 (de) | 1999-02-13 | 2000-08-17 | Walter Sebald | Protein mit einem Heparin-bindenden Epitop |
DE10026713A1 (de) * | 2000-05-30 | 2001-12-06 | Walter Sebald | Mutein einer Kette eines Proteins aus der Superfamilie des Wachstumsfaktors TGF-beta |
US20020114795A1 (en) * | 2000-12-22 | 2002-08-22 | Thorne Kevin J. | Composition and process for bone growth and repair |
ES2321068T3 (es) * | 2001-04-25 | 2009-06-02 | Eidgenossische Technische Hochschule Zurich | Matrices de suministro de farmacos para mejorar la curacion de heridas. |
US7160725B2 (en) | 2001-11-13 | 2007-01-09 | Curis, Inc. | Hedgehog signaling promotes the formation of three dimensional cartilage matrices |
US8546334B2 (en) | 2001-11-19 | 2013-10-01 | Scil Technology Gmbh | Device having osteoinductive and osteoconductive properties |
US20050008629A1 (en) * | 2002-05-08 | 2005-01-13 | Interpore Orthopaedics, A Delaware Corporation | Encapsulated AGF cells |
US7166133B2 (en) | 2002-06-13 | 2007-01-23 | Kensey Nash Corporation | Devices and methods for treating defects in the tissue of a living being |
JP4358741B2 (ja) | 2002-09-10 | 2009-11-04 | スキール テヒノロギー ゲーエムベーハー | 低酸素濃度下において骨誘導性タンパク質で被覆された金属インプラント |
US20050020506A1 (en) * | 2003-07-25 | 2005-01-27 | Drapeau Susan J. | Crosslinked compositions comprising collagen and demineralized bone matrix, methods of making and methods of use |
US7534264B2 (en) * | 2004-01-28 | 2009-05-19 | Ultradent Products, Inc. | Delivery system for bone growth promoting material |
ES2350939T3 (es) | 2004-03-10 | 2011-01-28 | Scil Technology Gmbh | Implantes recubiertos, su fabricación y uso de los mismos. |
US7621963B2 (en) * | 2005-04-13 | 2009-11-24 | Ebi, Llc | Composite bone graft material |
US20060233849A1 (en) * | 2005-04-13 | 2006-10-19 | Simon Bruce J | Composite bone graft material |
US8506983B2 (en) * | 2006-05-01 | 2013-08-13 | Warsaw Orthopedic, Inc. | Bone filler material |
US20100209470A1 (en) * | 2006-05-01 | 2010-08-19 | Warsaw Orthopedic, Inc. An Indiana Corporation | Demineralized bone matrix devices |
US7838022B2 (en) | 2006-05-01 | 2010-11-23 | Warsaw Orthopedic, Inc | Malleable implants containing demineralized bone matrix |
US7771741B2 (en) * | 2006-05-01 | 2010-08-10 | Warsaw Orthopedic, Inc | Demineralized bone matrix devices |
US7718616B2 (en) | 2006-12-21 | 2010-05-18 | Zimmer Orthobiologics, Inc. | Bone growth particles and osteoinductive composition thereof |
US9056150B2 (en) * | 2007-12-04 | 2015-06-16 | Warsaw Orthopedic, Inc. | Compositions for treating bone defects |
CA2710798A1 (en) | 2007-12-28 | 2009-07-09 | Kuros Biosurgery Ag | Pdgf fusion proteins incorporated into fibrin foams |
US8840913B2 (en) * | 2008-03-27 | 2014-09-23 | Warsaw Orthopedic, Inc. | Malleable multi-component implants and materials therefor |
WO2010074039A1 (ja) | 2008-12-26 | 2010-07-01 | 旭硝子株式会社 | エチレン/テトラフルオロエチレン共重合体の造粒方法 |
US11078248B2 (en) | 2010-03-19 | 2021-08-03 | Lifenet Health | BMP peptides and methods of use |
EP2550006B1 (de) * | 2010-03-24 | 2018-08-22 | Lifenet Health | Bmp-4-peptide und verwendungsverfahren dafür |
WO2012048275A2 (en) | 2010-10-08 | 2012-04-12 | Caridianbct, Inc. | Configurable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system |
AU2011329054B2 (en) | 2010-11-15 | 2015-05-28 | Zimmer Orthobiologics, Inc. | Bone void fillers |
EP2529764A1 (de) | 2011-05-31 | 2012-12-05 | Curasan AG | Biologisch degradierbares kompositmaterial |
US10207027B2 (en) | 2012-06-11 | 2019-02-19 | Globus Medical, Inc. | Bioactive bone graft substitutes |
US9539286B2 (en) | 2013-10-18 | 2017-01-10 | Globus Medical, Inc. | Bone grafts including osteogenic stem cells, and methods relating to the same |
US9486483B2 (en) | 2013-10-18 | 2016-11-08 | Globus Medical, Inc. | Bone grafts including osteogenic stem cells, and methods relating to the same |
US10633625B2 (en) | 2013-11-16 | 2020-04-28 | Terumo Bct, Inc. | Expanding cells in a bioreactor |
US9579421B2 (en) | 2014-02-07 | 2017-02-28 | Globus Medical Inc. | Bone grafts and methods of making and using bone grafts |
US9463264B2 (en) | 2014-02-11 | 2016-10-11 | Globus Medical, Inc. | Bone grafts and methods of making and using bone grafts |
EP3122866B1 (de) | 2014-03-25 | 2019-11-20 | Terumo BCT, Inc. | Passives ersetzen von medien |
JP6830059B2 (ja) | 2014-09-26 | 2021-02-17 | テルモ ビーシーティー、インコーポレーテッド | スケジュール化された細胞フィーディング |
US10016529B2 (en) | 2015-06-10 | 2018-07-10 | Globus Medical, Inc. | Biomaterial compositions, implants, and methods of making the same |
US11426489B2 (en) | 2015-06-10 | 2022-08-30 | Globus Medical, Inc. | Biomaterial compositions, implants, and methods of making the same |
WO2017004592A1 (en) | 2015-07-02 | 2017-01-05 | Terumo Bct, Inc. | Cell growth with mechanical stimuli |
EP3464565A4 (de) | 2016-05-25 | 2020-01-01 | Terumo BCT, Inc. | Zellexpansion |
US11104874B2 (en) | 2016-06-07 | 2021-08-31 | Terumo Bct, Inc. | Coating a bioreactor |
US11685883B2 (en) | 2016-06-07 | 2023-06-27 | Terumo Bct, Inc. | Methods and systems for coating a cell growth surface |
WO2018184028A2 (en) | 2017-03-31 | 2018-10-04 | Terumo Bct, Inc. | Cell expansion |
US11624046B2 (en) | 2017-03-31 | 2023-04-11 | Terumo Bct, Inc. | Cell expansion |
US11896736B2 (en) | 2020-07-13 | 2024-02-13 | Globus Medical, Inc | Biomaterial implants and methods of making the same |
Family Cites Families (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US621146A (en) * | 1899-03-14 | Presser-foot for sewing-machines | ||
CH595293A5 (de) * | 1975-02-20 | 1978-02-15 | Battelle Memorial Institute | |
US4294753A (en) * | 1980-08-04 | 1981-10-13 | The Regents Of The University Of California | Bone morphogenetic protein process |
US4455256A (en) * | 1981-05-05 | 1984-06-19 | The Regents Of The University Of California | Bone morphogenetic protein |
US4394370A (en) * | 1981-09-21 | 1983-07-19 | Jefferies Steven R | Bone graft material for osseous defects and method of making same |
US4434094A (en) * | 1983-04-12 | 1984-02-28 | Collagen Corporation | Partially purified osteogenic factor and process for preparing same from demineralized bone |
CA1229789A (en) * | 1983-06-06 | 1987-12-01 | David Baylink | Polypeptides exhibiting skeletal growth factor activity |
US4795804A (en) * | 1983-08-16 | 1989-01-03 | The Regents Of The University Of California | Bone morphogenetic agents |
NZ210699A (en) * | 1984-01-04 | 1989-06-28 | Int Genetic Eng | Isolation of an osteogenic protein of the p3 immunologically related family |
US4804744A (en) * | 1984-01-04 | 1989-02-14 | International Genetic Engineering, Inc. | Osteogenic factors |
US4563489A (en) * | 1984-02-10 | 1986-01-07 | University Of California | Biodegradable organic polymer delivery system for bone morphogenetic protein |
GB8413319D0 (en) * | 1984-05-24 | 1984-06-27 | Oliver Roy Frederick | Biological material |
US4620327A (en) * | 1984-07-05 | 1986-11-04 | Caplan Arnold I | Process of adapting soluble bone protein for use in stimulating osteoinduction |
ATE128715T1 (de) * | 1984-07-16 | 1995-10-15 | Celtrix Pharma | Polypeptide induzierende faktoren in knochen und knorpel. |
US4843063A (en) * | 1984-07-16 | 1989-06-27 | Collagen Corporation | Polypeptide cartilage-inducing factors found in bone |
US4563350A (en) * | 1984-10-24 | 1986-01-07 | Collagen Corporation | Inductive collagen based bone repair preparations |
US4817190A (en) | 1985-08-27 | 1989-03-28 | Motorola, Inc. | Method for dynamically regrouping subscribers on a communications system |
US5187076A (en) * | 1986-07-01 | 1993-02-16 | Genetics Institute, Inc. | DNA sequences encoding BMP-6 proteins |
US4877864A (en) * | 1987-03-26 | 1989-10-31 | Genetics Institute, Inc. | Osteoinductive factors |
US5108922A (en) * | 1986-07-01 | 1992-04-28 | Genetics Institute, Inc. | DNA sequences encoding BMP-1 products |
US5013649A (en) * | 1986-07-01 | 1991-05-07 | Genetics Institute, Inc. | DNA sequences encoding osteoinductive products |
IL83003A (en) * | 1986-07-01 | 1995-07-31 | Genetics Inst | Factors that soak bone formation |
US5106748A (en) * | 1986-07-01 | 1992-04-21 | Genetics Institute, Inc. | Dna sequences encoding 5 proteins |
ZA874681B (en) * | 1986-07-01 | 1988-04-27 | Genetics Inst | Novel osteoinductive factors |
DE3775363D1 (de) * | 1986-10-22 | 1992-01-30 | Biotechnolog Forschung Gmbh | Wachstumstimulierendes material, herstellungsverfahren und therapeutische zusammensetzung. |
EP0336760A3 (de) * | 1988-04-06 | 1991-03-13 | Celtrix Pharmaceuticals, Inc. | Knochenwachstum induzierendes Protein |
US6919308B2 (en) * | 1988-04-08 | 2005-07-19 | Stryker Corporation | Osteogenic devices |
US4975526A (en) * | 1989-02-23 | 1990-12-04 | Creative Biomolecules, Inc. | Bone collagen matrix for zenogenic implants |
US6586388B2 (en) * | 1988-04-08 | 2003-07-01 | Stryker Corporation | Method of using recombinant osteogenic protein to repair bone or cartilage defects |
US5258494A (en) * | 1988-04-08 | 1993-11-02 | Stryker Corporation | Osteogenic proteins |
US5266683A (en) * | 1988-04-08 | 1993-11-30 | Stryker Corporation | Osteogenic proteins |
US5011691A (en) * | 1988-08-15 | 1991-04-30 | Stryker Corporation | Osteogenic devices |
US5344654A (en) * | 1988-04-08 | 1994-09-06 | Stryker Corporation | Prosthetic devices having enhanced osteogenic properties |
US5250302A (en) * | 1988-04-08 | 1993-10-05 | Stryker Corporation | Osteogenic devices |
US5108753A (en) * | 1988-04-08 | 1992-04-28 | Creative Biomolecules | Osteogenic devices |
DE68929453T2 (de) * | 1988-04-08 | 2003-11-20 | Stryker Corp | Osteogene Vorrichtungen |
US5354557A (en) * | 1988-04-08 | 1994-10-11 | Stryker Corporation | Osteogenic devices |
EP0408649A4 (en) * | 1988-04-08 | 1991-11-27 | Genetics Institute, Inc. | Bone and cartilage inductive compositions |
US5162114A (en) * | 1989-02-23 | 1992-11-10 | Stryker Corporation | Bone collagen matrix for xenogenic implants |
US5324819A (en) * | 1988-04-08 | 1994-06-28 | Stryker Corporation | Osteogenic proteins |
US5106626A (en) * | 1988-10-11 | 1992-04-21 | International Genetic Engineering, Inc. | Osteogenic factors |
US5284756A (en) * | 1988-10-11 | 1994-02-08 | Lynn Grinna | Heterodimeric osteogenic factor |
ATE162223T1 (de) * | 1989-03-28 | 1998-01-15 | Genetics Inst | Osteoinduktive zusammensetzungen |
WO1991002744A1 (en) * | 1989-08-21 | 1991-03-07 | Celtrix Laboratories, Inc. | Bone-specific protein |
US5645591A (en) * | 1990-05-29 | 1997-07-08 | Stryker Corporation | Synthetic bone matrix |
US5674844A (en) * | 1991-03-11 | 1997-10-07 | Creative Biomolecules, Inc. | Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases |
US5656593A (en) * | 1991-03-11 | 1997-08-12 | Creative Biomolecules, Inc. | Morphogen induced periodontal tissue regeneration |
US5652337A (en) * | 1991-03-11 | 1997-07-29 | Creative Biomolecules, Inc. | OP-3-induced morphogenesis |
US6022853A (en) * | 1991-08-30 | 2000-02-08 | Creative Biomolecules, Inc. | Morphogen-enriched dietary composition |
US5906827A (en) * | 1994-06-03 | 1999-05-25 | Creative Biomolecules, Inc. | Matrix for the manufacture of autogenous replacement body parts |
US5674292A (en) * | 1995-06-07 | 1997-10-07 | Stryker Corporation | Terminally sterilized osteogenic devices and preparation thereof |
US6281195B1 (en) * | 1997-02-07 | 2001-08-28 | Stryker Corporation | Matrix-free osteogenic devices, implants and methods of use thereof |
US20010016646A1 (en) * | 1998-03-20 | 2001-08-23 | David C. Rueger | Osteogenic devices and methods of use thereof for repair of endochondral bone, osteochondral and chondral defects |
US20030032586A1 (en) * | 1997-05-15 | 2003-02-13 | David C. Rueger | Compositions for morphogen-induced osteogenesis |
US20020015985A1 (en) * | 1998-02-18 | 2002-02-07 | Haruo Takahashi | Immobilized enzymes |
US6677432B1 (en) * | 1998-10-07 | 2004-01-13 | Stryker Corporation | Mutations of the C-terminal portion of TGF-β superfamily proteins |
-
1989
- 1989-04-07 DE DE68929453T patent/DE68929453T2/de not_active Expired - Lifetime
- 1989-04-07 AT AT89904986T patent/ATE134647T1/de not_active IP Right Cessation
- 1989-04-07 EP EP95201872A patent/EP0714665B1/de not_active Expired - Lifetime
- 1989-04-07 DE DE0001221484T patent/DE01201555T1/de active Pending
- 1989-04-07 AT AT89904959T patent/ATE142644T1/de not_active IP Right Cessation
- 1989-04-07 WO PCT/US1989/001469 patent/WO1989009788A2/en active IP Right Grant
- 1989-04-07 AU AU34449/89A patent/AU628050B2/en not_active Expired
- 1989-04-07 EP EP96200044A patent/EP0723013B1/de not_active Revoked
- 1989-04-07 DE DE68929472T patent/DE68929472T2/de not_active Revoked
- 1989-04-07 EP EP01201555A patent/EP1221484A3/de not_active Withdrawn
- 1989-04-07 DE DE68925773T patent/DE68925773T2/de not_active Expired - Lifetime
- 1989-04-07 EP EP89904986A patent/EP0362367B1/de not_active Expired - Lifetime
- 1989-04-07 EP EP89904959A patent/EP0372031B1/de not_active Expired - Lifetime
- 1989-04-07 JP JP1504771A patent/JP2522568B2/ja not_active Expired - Lifetime
- 1989-04-07 AU AU35305/89A patent/AU618357B2/en not_active Expired
- 1989-04-07 DE DE0001225225T patent/DE01201546T1/de active Pending
- 1989-04-07 DE DE68927153T patent/DE68927153T2/de not_active Expired - Lifetime
- 1989-04-07 CA CA596143A patent/CA1341610C/en not_active Expired - Fee Related
- 1989-04-07 JP JP1504777A patent/JP2548414B2/ja not_active Expired - Lifetime
- 1989-04-07 AT AT96200044T patent/ATE243254T1/de not_active IP Right Cessation
- 1989-04-07 CA CA000596144A patent/CA1338663C/en not_active Expired - Lifetime
- 1989-04-07 WO PCT/US1989/001453 patent/WO1989009787A2/en active IP Right Grant
- 1989-04-07 EP EP01201546A patent/EP1225225A3/de not_active Withdrawn
- 1989-04-07 AT AT95201872T patent/ATE231523T1/de not_active IP Right Cessation
-
1995
- 1995-04-04 US US08/417,071 patent/US5814604A/en not_active Expired - Lifetime
- 1995-10-11 JP JP7263371A patent/JPH08187084A/ja active Pending
-
1996
- 1996-01-11 JP JP8003435A patent/JP2933867B2/ja not_active Expired - Lifetime
- 1996-04-05 JP JP8084325A patent/JP2869381B2/ja not_active Expired - Lifetime
-
1998
- 1998-05-07 US US09/074,299 patent/US6297213B1/en not_active Expired - Fee Related
-
2001
- 2001-09-19 US US09/956,582 patent/US20030124169A1/en not_active Abandoned
-
2003
- 2003-09-25 US US10/671,317 patent/US20050054825A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE01201546T1 (de) | Osteogene Einrichtungen | |
DE60006356T2 (de) | Hochmineralisierte osteogene schwammzusammensetzungen und ihre verwendung | |
DE69531779T3 (de) | Herstellung von autogenen körperersatzteilen | |
DE60020526T2 (de) | Osteogene pastenzusammensetzungen und ihre verwendung | |
DE69626205T2 (de) | Terminal-sterilisierte osteogene vorrichtungen und ihre herstellung | |
EP0520237B1 (de) | Knochenersatzmaterial mit Fibroblasten-Wachstums-Faktoren | |
RU2104703C1 (ru) | Способ получения материала для остеопластики и полученный этим способом материал | |
DE60023754T2 (de) | Künstlicher kalciumphosphatknochen als osteokonduktives und biologisch abbauba res knochenersatzmaterial | |
US6679918B1 (en) | Implantable putty material | |
DE69821774T2 (de) | Biologisch abbaubare Verbundwerkstoffe | |
DE69333556T2 (de) | Injizierbare keramische Zusammensetzungen sowie Verfahren für ihre Herstellung und Verwendung | |
DE69333878T2 (de) | Prothesen mit erhöhten osteogenen eigenschaften | |
DE69434122T2 (de) | Osteogenisches produkt und verwendung | |
US8497236B2 (en) | Implantable putty material | |
CA2280966C (en) | Implantable collagen-containing putty material | |
JPH01256967A (ja) | 胎盤からとった注射が可能な軟組織補綴物とその製法 | |
DE3519073A1 (de) | Kuenstliches knochenerzeugendes biomaterial und verfahren zu seiner herstellung | |
DE3810803C2 (de) | ||
EP2273997A2 (de) | Verfahren und zusammensetzung zur regeneration von gewebe mit hilfe von stamm- oder knochenmarkzellen | |
Papadopoulos et al. | In vitro evaluation of the mitogenic effect of platelet‐derived growth factor‐BB on human periodontal ligament cells cultured with various bone allografts | |
EP0550458B1 (de) | Knochenwachstumsstimulator | |
RU2476236C1 (ru) | Композиционный материал для восстановления дефектов костной ткани, способ его получения и применение | |
CN115137883B (zh) | 一种仿生复合矿化支架及其制备方法 | |
EP1171176A1 (de) | Implantat für die wiederherstellung von wirbeln und röhrenknochen | |
WO2020156387A1 (zh) | 干细胞发生器及其构建方法 |